Yubo International Biotech Limited (YBGJ)

OTCMKTS · Delayed Price · Currency is USD

0.0080

0.00 (0.00%)

At close: Jul 14, 2026

-89.19% (1Y)

Market Cap	1.36M -98.2%
Revenue (ttm)	12.35K +256.0%
Net Income	-916.23K
EPS	-0.01
Shares Out	170.42M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,000
Open	0.0080
Previous Close	0.0080
Day's Range	0.0080 - 0.0080
52-Week Range	0.0066 - 0.1776
Beta	0.67
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About YBGJ

Yubo International Biotech Limited, through its subsidiaries, focuses on the research, development, and application of endometrial stem cells. The company offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. It also provides light application products, including respiratory atomization products; cell basidiomycetes compound dr... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

CEO Yang Wang

Employees 14

Stock Exchange OTCMKTS

Ticker Symbol YBGJ

Full Company Profile

Financial Performance

In 2025, YBGJ's revenue was $12,353, an increase of 255.99% compared to the previous year's $3,470. Losses were -$1.08 million, -39.21% less than in 2024.

Financial Statements